Evommune, INC. (EVMN) SEC Filings — 2025
4 SEC filings for Evommune, INC. (EVMN) in 2025.
Filings
- Evommune Narrows Loss on Revenue Jump, Secures $65M in New Funding — 10-Q · Dec 11, 2025
- Evommune, INC. 8-K Filing — 8-K · Nov 7, 2025
- Evommune IPO Targets $15-$17/Share Amid Promising Phase 2 Data — S-1/A · Oct 17, 2025
- Evommune Files S-1 for IPO, Advances Chronic Inflammation Pipeline — S-1 · Oct 9, 2025